Pinealon

Bioregulator Peptideresearch

Also known as: EDR Peptide, Glu-Asp-Arg

A short tripeptide bioregulator that targets the pineal gland, supporting melatonin production, sleep quality, and neuroprotection.

SponsoredPartner with us — advertise hereContact us

Overview

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Russian scientist Vladimir Khavinson as part of the bioregulator peptide family. It specifically targets the pineal gland, the brain's melatonin-producing center. Research suggests Pinealon can help restore declining melatonin production associated with aging, improve sleep architecture, and provide neuroprotective effects. It is part of a broader class of Khavinson peptides that target specific organs and tissues.

Mechanism of Action

Pinealon acts as a gene regulator targeting pinealocytes (pineal gland cells): (1) Binds to DNA in pineal gland cells, modulating gene expression related to melatonin synthesis; (2) Restores age-related decline in melatonin production; (3) Provides antioxidant protection to pineal tissue; (4) May influence circadian rhythm regulation; (5) Shows neuroprotective effects by reducing oxidative stress in brain tissue.

Molecular Formula

C15H25N5O8

Molecular Weight

407.38 g/mol

Sequence

Glu-Asp-Arg

Dosage Protocols

Dose Range

10mg20mg

Frequency

Daily

Route

oral (sublingual or capsule)

Cycle Length

10-30 days, repeated periodically

Often taken as sublingual capsules. Cycle 10 days on, break, repeat.

Source: Khavinson research protocols

🧮 Personalized Dosage Calculator

💰 Estimated Pricing

$25 – $60per cycle (10-30 days)research

Typical Supply

Sublingual capsules

Last Updated

2026-02

Available from specialty bioregulator suppliers.

⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.

Side Effects

EffectSeverity
mild
mild

Pros & Cons

Non-hormonal approach to improving melatonin production

Oral administration (no injections needed)

Short cycles with lasting effects

Good safety profile in research

Supports natural circadian rhythm

Limited Western clinical trials

Primarily researched in Russia

Effects may be subtle

Not FDA-approved

Mechanism not fully understood

Research Studies

🩸 Blood Work

No specific bloodwork requirements reported for this peptide. General health panels are always recommended before starting any peptide protocol.

Legal Status

Available as a research peptide and supplement in many countries. Not FDA-approved.

Readers Also Viewed

Related Peptides

SponsoredPartner with us — advertise hereContact us